Skip to main content

IRADIMED CORP

For the period ended Jun 30, 2026. Filed Jul 31, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 31, 2026

IRMD$86.94+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Conten

Page
Cautionary Note Regarding Forward-Looking Statements3
Part IFinancial Information6
Item 1Financial Statements6
(a) Condensed Balance Sheets as of June 30, 2026 (Unaudited) and December 31, 2025 (Audited)6
(b) Condensed Statements of Operations for the three and six months ended June 30, 2026 and 2025 (Unaudited)7
(c) Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2026 and 2025 (Unaudited)8
(d) Condensed Statements of Cash Flows for the six months ended June 30, 2026 and 2025 (Unaudited)9
(e) Notes to Unaudited Condensed Financial Statements10
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3Quantitative and Qualitative Disclosures About Market Risk24
Item 4Controls and Procedures25
Part IIOther Information26
Item 1Legal Proceedings26
Item 1ARisk Factors26
Item 2Unregistered Sale of Equity Securities and Use of Proceeds26
Item 3Default Upon Senior Securities26
Item 4Mine Safety Disclosures26
Item 5Other Information26
Item 6Exhibits27
Signatures28
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.